Global Memantine Hydrochloride Tablets Market Growth 2025-2031
Description
The global Memantine Hydrochloride Tablets market size is predicted to grow from US$ 107 million in 2025 to US$ 129 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Memantine Hydrochloride Tablets are oral pharmaceutical preparations containing memantine hydrochloride, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. This medication works by regulating the activity of glutamate, a neurotransmitter involved in neuronal signaling, to protect brain cells from excessive excitotoxicity associated with neurodegenerative processes. Primarily indicated for the treatment of moderate to severe Alzheimer’s disease, these tablets aim to slow the progression of cognitive and functional decline, such as memory loss, impaired reasoning, and behavioral changes, in patients with this progressive dementia. Memantine hydrochloride is formulated in tablet form for convenient administration, with dosages typically titrated based on individual patient response and tolerance to minimize side effects like dizziness, headache, or gastrointestinal discomfort. The drug’s mechanism targets the NMDA receptor to maintain physiological glutamate transmission while blocking excessive stimulation, thereby supporting synaptic function and potentially preserving cognitive abilities in affected individuals.
United States market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Memantine Hydrochloride Tablets players cover Teva Pharmaceuticals USA, Sun Pharma, Kabir Lifesciences, Upsher-Smith, Taj Pharma India Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Memantine Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Memantine Hydrochloride Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Memantine Hydrochloride Tablets sales for 2025 through 2031. With Memantine Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Memantine Hydrochloride Tablets industry.
This Insight Report provides a comprehensive analysis of the global Memantine Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Memantine Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Memantine Hydrochloride Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Memantine Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Memantine Hydrochloride Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Memantine Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Immediate-Release Tablets
Extended-Release Tablets
Segmentation by Application:
Online Pharmacy
Retail Pharmacy
Hospital Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Teva Pharmaceuticals USA
Sun Pharma
Kabir Lifesciences
Upsher-Smith
Taj Pharma India Limited
Psycogen Captab
Actiza Pharmaceutical Pvt. Ltd.
Ajanta Pharma Ltd.
Sharon Bio-medicine Limited
Consern Pharma Limited
United Laboratories
Aripolis Biotech Pvt. Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Memantine Hydrochloride Tablets market?
What factors are driving Memantine Hydrochloride Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Memantine Hydrochloride Tablets market opportunities vary by end market size?
How does Memantine Hydrochloride Tablets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Memantine Hydrochloride Tablets are oral pharmaceutical preparations containing memantine hydrochloride, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. This medication works by regulating the activity of glutamate, a neurotransmitter involved in neuronal signaling, to protect brain cells from excessive excitotoxicity associated with neurodegenerative processes. Primarily indicated for the treatment of moderate to severe Alzheimer’s disease, these tablets aim to slow the progression of cognitive and functional decline, such as memory loss, impaired reasoning, and behavioral changes, in patients with this progressive dementia. Memantine hydrochloride is formulated in tablet form for convenient administration, with dosages typically titrated based on individual patient response and tolerance to minimize side effects like dizziness, headache, or gastrointestinal discomfort. The drug’s mechanism targets the NMDA receptor to maintain physiological glutamate transmission while blocking excessive stimulation, thereby supporting synaptic function and potentially preserving cognitive abilities in affected individuals.
United States market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Memantine Hydrochloride Tablets players cover Teva Pharmaceuticals USA, Sun Pharma, Kabir Lifesciences, Upsher-Smith, Taj Pharma India Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Memantine Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Memantine Hydrochloride Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Memantine Hydrochloride Tablets sales for 2025 through 2031. With Memantine Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Memantine Hydrochloride Tablets industry.
This Insight Report provides a comprehensive analysis of the global Memantine Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Memantine Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Memantine Hydrochloride Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Memantine Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Memantine Hydrochloride Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Memantine Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Immediate-Release Tablets
Extended-Release Tablets
Segmentation by Application:
Online Pharmacy
Retail Pharmacy
Hospital Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Teva Pharmaceuticals USA
Sun Pharma
Kabir Lifesciences
Upsher-Smith
Taj Pharma India Limited
Psycogen Captab
Actiza Pharmaceutical Pvt. Ltd.
Ajanta Pharma Ltd.
Sharon Bio-medicine Limited
Consern Pharma Limited
United Laboratories
Aripolis Biotech Pvt. Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Memantine Hydrochloride Tablets market?
What factors are driving Memantine Hydrochloride Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Memantine Hydrochloride Tablets market opportunities vary by end market size?
How does Memantine Hydrochloride Tablets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
118 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Memantine Hydrochloride Tablets by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Memantine Hydrochloride Tablets by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
